Foxo4 Dri Research
Product image coming soon
FOXO4-DRI: Senescent Cell Biology and Apoptotic Signalling Research
FOXO4-DRI is a synthetic D-retro-inverso (DRI) peptide studied in laboratory settings for its role in senescent cell biology. It is designed to interfere with the FOXO4-p53 protein-protein interaction that is studied as a survival mechanism in senescent cells, making it a research tool for investigating cellular senescence and apoptotic signalling.
Molecular Data
| Property | Value |
|---|---|
| Molecular weight | Approximately 2.8 kDa |
| Peptide type | D-retro-inverso (DRI) peptide |
| Target interaction | FOXO4-p53 protein-protein interaction |
| Based on | FOXO4 helix-2 domain sequence |
| Purity | greater than or equal to 98% as verified by HPLC |
| Form | Lyophilised powder |
| Storage | -20 degrees C, protected from light and moisture |
| Reconstitution | DMSO or sterile water recommended |
FOXO4-DRI: Senescent Cell Apoptotic Signalling
D-Retro-Inverso Peptide Design
FOXO4-DRI is a D-retro-inverso peptide — a peptide composed entirely of D-amino acids (the mirror-image form of natural L-amino acids) arranged in the reverse sequence of the native FOXO4 helix-2 domain. This design strategy creates a peptide that:
Resists proteolytic degradation. D-amino acids are not recognised by most cellular proteases, which evolved to cleave L-amino acid peptide bonds. This extends the research tool's stability in cell culture and in vivo models dramatically compared to the native L-peptide sequence.
Maintains structural mimicry. The combination of D-amino acids and reversed sequence creates a mirror image of the native helix conformation, preserving the spatial arrangement of key side chains required for protein-protein interaction inhibition.
Cell-permeability. FOXO4-DRI contains a cell-penetrating segment derived from the FOXO4 sequence that enables intracellular delivery — important for accessing the nucleus where FOXO4-p53 interactions occur.
Cellular Senescence Research Context
Cellular senescence is a state of stable cell cycle arrest studied extensively in the context of ageing, cancer, and tissue dysfunction. Senescent cells accumulate with age and in damaged tissues, and they secrete a complex mixture of cytokines, matrix metalloproteases, and growth factors known as the senescence-associated secretory phenotype (SASP).
Research has identified that senescent cells upregulate survival pathways that prevent their removal by apoptosis. The FOXO4-p53 interaction has been studied as one such survival mechanism: in senescent cells, FOXO4 is proposed to sequester p53 in the nucleus, preventing p53-mediated apoptosis transcription.
FOXO4-p53 Interaction Research
FOXO4-DRI is used as a tool compound for studying the functional consequences of FOXO4-p53 interaction disruption in cell models. Research has examined changes in nuclear p53 localisation, caspase activation, and apoptotic signalling in senescent cells following FOXO4-DRI treatment.
This connects FOXO4-DRI research to broader cellular ageing biology studied with NAD+ (sirtuin-mediated senescence pathways) and MOTS-c (mitochondrial stress signalling relevant to cellular ageing).
Senolytic Research Tool Comparison
| Compound | Target | Mechanism | Cell type selectivity |
|---|---|---|---|
| FOXO4-DRI | FOXO4-p53 interaction | D-retro-inverso peptide | Senescent cells |
| Navitoclax (ABT-263) | BCL-2/BCL-XL | BH3 mimetic | Broad — platelet toxicity |
| Dasatinib + Quercetin | Src kinase / flavonoid targets | Multi-target | Broad |
| HSP90 inhibitors | HSP90 client proteins | Chaperone disruption | Partial selectivity |
The Senescence-Associated Secretory Phenotype (SASP)
Senescent cells do not simply stop dividing — they remain metabolically active and secrete a complex mixture of inflammatory mediators known as the SASP. Key SASP components studied in laboratory models include:
- Pro-inflammatory cytokines: IL-6, IL-8, IL-1alpha, IL-1beta, TNF-alpha
- Matrix metalloproteinases: MMP-1, MMP-3, MMP-9, MMP-10, MMP-13
- Growth factors: VEGF, HGF, EGF
- Chemokines: CXCL1, CXCL2, CXCL5
The SASP is regulated in part through NFkB and mTOR signalling. Research using FOXO4-DRI to induce senescent cell apoptosis examines whether SASP factors decline following senescent cell clearance — a key endpoint in senolytic research.
Frequently Asked Questions
What makes the D-retro-inverso design of FOXO4-DRI particularly useful?
Standard L-peptides are rapidly degraded by cellular proteases. By using all D-amino acids in the reverse sequence (retro-inverso design), FOXO4-DRI achieves complete resistance to proteolytic degradation while maintaining the spatial arrangement of key side chains needed for FOXO4-p53 interaction inhibition. This protease resistance means the peptide can be used in cell culture for extended periods without degradation, and can penetrate cells and reach the nucleus — where FOXO4-p53 interactions occur — intact.
How do researchers identify senescent cells for FOXO4-DRI research?
Common senescence markers used to confirm cell populations in FOXO4-DRI research include: SA-beta-galactosidase (beta-galactosidase activity at pH 6.0, a classic senescence marker), p21 and p16 expression (cyclin-dependent kinase inhibitors upregulated in senescence), H2AX gamma foci (DNA damage markers), SAHF (senescence-associated heterochromatin foci), and SASP cytokine secretion. Researchers typically use multiple markers together since no single marker is fully specific for senescence.
Published Research References
For laboratory and analytical research purposes only. Not for human or veterinary use. No dosage or administration guidance is provided or implied.
Related research compounds: NAD+ | MOTS-c | 5-Amino-1MQ